Takeda and Shire shake hands on £46 billion deal

8 May 2018
mergers-acquisitions-big

Takeda  Pharmaceutical (TYO: 4502) and Shire (LSE: SHP) have reached agreement on the Japanese pharma major’s takeover of the Ireland-headquartered rare disease drugmaker.

The deal, which values Shire at £46 billion ($62 billion), will see Takeda shareholders own around 50% of the combined group upon completion, and brings nearer the likely Takeda pursuit of Shire, which has lasted for several weeks, but still requires shareholder's approval.

"We firmly believe that this combination recognizes the strong growth potential of our leading products and innovative pipeline and is in the best interests of our shareholders, our patients and the communities we serve"

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical